← Open Payments lookup

JENNIFER RUSSUM: Open Payments

NPI 1376951921 · CLINTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,399 in 71 payments from 16 companies in 2025. Trend: 2023 $363 · 2024 $841 · 2025 $1,399

Food & beverage: $1,399
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP15$291
ABBVIE INC.17$260
Novo Nordisk Inc8$143
Kowa Pharmaceuticals America, Inc.2$120
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$115
Lilly USA, LLC3$81
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$76
Amgen Inc.3$71
Otsuka America Pharmaceutical, Inc.3$52
Stryker Corporation1$49

Products named: FARXIGA, VRAYLAR, ZORYVE, CAPLYTA, Ozempic, XIFAXAN, MOUNJARO, UBRELVY.

Industry payments across MS — which companies pay providers there.